MB
GILD icon

MidFirst Bank’s Gilead Sciences GILD Stock Holding History

MidFirst Bank’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$810K Hold
6,414
– – 0.06% 180
2026
Q1 		$894K Sell
6,414
-2,553
-28% -$358K 0.07% 168
2025
Q4 		$1.1M Buy
+8,967
New +$1.09M 0.09% 161

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MidFirst Bank's GILD Position: Q2 2026 in Review

MidFirst Bank held its Gilead Sciences (GILD) position steady in Q2 2026 at 6,414 shares worth $810K. The position accounts for 0.06% of the portfolio, ranked #180.

MidFirst Bank first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.1M in Q4 2025. 1,926 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • MidFirst Bank held 6,414 shares of Gilead Sciences worth $810K as of Q2 2026.
  • MidFirst Bank left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.06% of MidFirst Bank's portfolio in Q2 2026, its #180 holding.
  • MidFirst Bank first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • MidFirst Bank's Gilead Sciences position peaked at $1.1M in Q4 2025.
  • 1,926 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on MidFirst Bank's 13F filing for Q2 2026, filed 7 Aug 2026.